
Bioptimus is building the first universal AI foundation model for biology, aiming to capture the complex laws of biology for breakthrough discoveries and innovations in biomedicine and environmental science. They leverage a world-class team of engineers and research scientists with expertise in machine learning and biological data. Bioptimus benefits from strategic partnerships for high-volume, diverse, multimodal, and multiscale data, along with best-in-class GPU resources and a secure computing environment for training their models. Data security is a priority, enabling safe access and management of vast datasets. The company has launched H-optimus-1, a foundation model for pathology, and H-optimus-0, the world's largest open-source AI foundation model for pathology. They have also secured access to NVIDIA compute resources and are part of the FrenchTech Next 40/120 Program.

Bioptimus is building the first universal AI foundation model for biology, aiming to capture the complex laws of biology for breakthrough discoveries and innovations in biomedicine and environmental science. They leverage a world-class team of engineers and research scientists with expertise in machine learning and biological data. Bioptimus benefits from strategic partnerships for high-volume, diverse, multimodal, and multiscale data, along with best-in-class GPU resources and a secure computing environment for training their models. Data security is a priority, enabling safe access and management of vast datasets. The company has launched H-optimus-1, a foundation model for pathology, and H-optimus-0, the world's largest open-source AI foundation model for pathology. They have also secured access to NVIDIA compute resources and are part of the FrenchTech Next 40/120 Program.
What they do: Build multi-scale, multimodal foundation models for biology (H-Optimus series)
Headquarters: Paris, Île-de-France, France
Funding: $76M total (seed + follow-on)
Notable releases: H-Optimus-0 (open-source) and H-Optimus-1 (pathology foundation model)
Biotechnology research and AI for biology (pathology, multimodal biological data)
2024
Biotechnology Research
$35M
Seed round with participation from Bpifrance Large Venture, Cathay Innovation, Headline, Hummingbird, NJF Capital, Owkin, Top Harvest Capital and others
$41M
Follow-on round bringing disclosed total funding to $76M; participants included Sofinnova Partners, Bpifrance, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Sunrise and others
“Venture-backed with participation from major European and international life-science and AI investors (e.g., Cathay Innovation, Sofinnova Partners, Bpifrance)”
| Company |
|---|
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in October 2023. Backed by leading international venture capitalists, our world-class team of scientists and engineers is redefining the frontiers of AI and life sciences.
What you'll be doing As our Senior Director for Business Development, you will have ownership over the following strategic domains:
Influence the go-to-market strategy:
Revenue Growth and Target Achievement:
Stakeholder Engagement:
Teamwork and Collaboration:
What you'll bring The successful candidate is a strategic thinker and a pragmatic builder, with a proven track record of scaling the business development function in a high-growth, technology-driven environment.
How to stand out:
The candidate journey
To be considered, please submit your CV in English .
We believe in a transparent and collaborative interview process. Here is what you can expect after submitting your application:
Screening: Once you have applied, the hiring team will review your application. If your experience and skills align with the role, you will be invited to a 30-minute introductory call with the Hiring Manager to discuss your background, motivations, and the position in more detail.
Interviews: Following a successful technical assessment, you will be invited to a series of interviews. The core stages of our process are outlined below. Please note that the order may be adapted and additional conversations may be included to ensure a comprehensive evaluation.
Live Case Study (1 hour): This stage may involve a live case study focused on technology, your sales experience, or a "Sell Bioptimus" exercise.
Tech / Product Oriented Interview (1 hour): This stage involves a discussion focused on the technical and product aspects of the role.
Tech Interview (30 min): Discuss our current technical setup and infrastructure with members of our Tech team responsible for the areas within this role's scope
Exec Interview: Meet with senior leadership to discuss your vision for the role and explore cultural alignment.
Offer: Following the completion of all interviews, our hiring team will make a final decision and will be in touch to share the outcome. If the team would like to move forward, we will contact you to discuss the details of our proposed offer. Please note that an offer is contingent upon the successful completion of a reference check.
Onboarding: We are happy to have you joining the team. Once you have accepted and signed your offer, we will be in touch to begin the process of onboarding you.
Why this is a unique opportunity
We believe that the unique contributions of all Bioptimists create our success. To ensure that our culture continues to incorporate everyone’s perspectives and experience, we never discriminate based on race, religion, national origin, gender identity or expression, sexual orientation, age, or marital, or disability status. Decisions related to hiring are made fairly, and we provide equal employment opportunities to all qualified candidates. We take responsibility for always striving to create an inclusive environment that makes every employee and candidate feel welcome.